Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Cutaneous extra nodal lymphoma relapse

View through CrossRef
ABSTRACT Introduction: Cutaneous lymphomas represent a unique group of lymphomas. Cutaneous lymphomas are the second most frequent extra nodal involvement; gastrointestinal involvement being the most frequent (Malkan et al. [1]). To the best of our knowledge few cases of cutaneous relapse of Non-Hodgkin Lymphoma (NHL) have been reported where there was an absence of primary cutaneous involvement. Case presentation: A case study of a 70-year-old woman who was referred for an excisional biopsy of a lesion on her left cheek in 2017. She had previously been diagnosed with NHL in 2009; disease involved the right groin lymph nodes. The patient completed a course of chemotherapy and was in remission. An excision of the lesion on the left upper cheek confirmed low-grade follicular lymphoma. A PET scan was performed after the histology from the lesion was confirmed which demonstrated moderate fluorodeoxyglucose (FDG) uptake in left cheek, left external iliac lymph nodes and left tonsil consistent with recurrence of lymphoma. Discussion: The majority of relapses of NHL occur in the first 2 years after the completion of treatment. Extra nodal lymphomas comprise 24-48 percent of cases. The reason for multifocal extra nodal lymphoma or preferential involvement of specific extra nodal sites at recurrence is not clear Extra nodal involvement involving skin accounts for 10 percent of cases. NHL typically relapses in the same involvement sites. First line treatment for solitary lesions includes surgical excision, antibiotics and radiotherapy. Conclusion: Disease relapse was not present in the primary involvement site. Furthermore, there was a cutaneous relapse where there was no primary cutaneous disease. Treatment involved systemic therapy for this patient given the nodal involvement found on the PET scan. Highlights
Title: Cutaneous extra nodal lymphoma relapse
Description:
ABSTRACT Introduction: Cutaneous lymphomas represent a unique group of lymphomas.
Cutaneous lymphomas are the second most frequent extra nodal involvement; gastrointestinal involvement being the most frequent (Malkan et al.
[1]).
To the best of our knowledge few cases of cutaneous relapse of Non-Hodgkin Lymphoma (NHL) have been reported where there was an absence of primary cutaneous involvement.
Case presentation: A case study of a 70-year-old woman who was referred for an excisional biopsy of a lesion on her left cheek in 2017.
She had previously been diagnosed with NHL in 2009; disease involved the right groin lymph nodes.
The patient completed a course of chemotherapy and was in remission.
An excision of the lesion on the left upper cheek confirmed low-grade follicular lymphoma.
A PET scan was performed after the histology from the lesion was confirmed which demonstrated moderate fluorodeoxyglucose (FDG) uptake in left cheek, left external iliac lymph nodes and left tonsil consistent with recurrence of lymphoma.
Discussion: The majority of relapses of NHL occur in the first 2 years after the completion of treatment.
Extra nodal lymphomas comprise 24-48 percent of cases.
The reason for multifocal extra nodal lymphoma or preferential involvement of specific extra nodal sites at recurrence is not clear Extra nodal involvement involving skin accounts for 10 percent of cases.
NHL typically relapses in the same involvement sites.
First line treatment for solitary lesions includes surgical excision, antibiotics and radiotherapy.
Conclusion: Disease relapse was not present in the primary involvement site.
Furthermore, there was a cutaneous relapse where there was no primary cutaneous disease.
Treatment involved systemic therapy for this patient given the nodal involvement found on the PET scan.
Highlights.

Related Results

Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract Introduction Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
Exploring the Association between Lymphoma and Inflammatory Bowel Disease in an Inner-City Academic Institution
Exploring the Association between Lymphoma and Inflammatory Bowel Disease in an Inner-City Academic Institution
Introduction: The incidence of lymphoma has been increasing over the past several decades, with data showing an estimated annual percentage change of 0.56%. There...
The Analysis of HIV-Associated Lymphoma in Japan
The Analysis of HIV-Associated Lymphoma in Japan
Abstract Background. The recent advance of antiretroviral therapy decreased the morbidity of opportunistic infections. However, the incidence of HIV-a...
Cutaneous T-Cell Lymphoma and Microbiota: Etiopathogenesis and Potential New Therapeutic Targets
Cutaneous T-Cell Lymphoma and Microbiota: Etiopathogenesis and Potential New Therapeutic Targets
Objective. To review the scientific literature related to human microbiota and cutaneous T-cell lymphoma. Methodology. An exploratory and systematic review of the articles retrieve...
Lymphomas
Lymphomas
Lymphoma is the fifth most common type of cancer in the United States, with 74,490 new cases estimated in 2009. Approximately 15% of patients with lymphoma have Hodgkin lymphoma; t...
Lymphomas
Lymphomas
Lymphoma is the fifth most common type of cancer in the United States, with 74,490 new cases estimated in 2009. Approximately 15% of patients with lymphoma have Hodgkin lymphoma; t...
Decoding the DIC-Lymphoma Relationship: A Nationwide Analysis of Increased Risk in Adult Patients
Decoding the DIC-Lymphoma Relationship: A Nationwide Analysis of Increased Risk in Adult Patients
Background: Disseminated intravascular coagulation (DIC) is a severe, often fatal condition characterized by systemic coagulation activation leading to both wides...
The Role of Whole Body STIR MRI in Assessing First Biochemical Relapse in Patients with Myeloma
The Role of Whole Body STIR MRI in Assessing First Biochemical Relapse in Patients with Myeloma
Background: Myeloma remains an incurable disease and most patients will relapse. The optimal timing of salvage initiation remains uncertain although there is a trend to treating ea...

Back to Top